Adtalem Global Education (NYSE:CVSA) Issues FY 2026 Earnings Guidance

Key Points

• Adtalem updated its FY 2026 guidance to EPS $7.950–$8.150 (slightly above the $7.90 consensus) and issued revenue guidance of $1.9 billion, in line with estimates.
• The company beat Q4 estimates, reporting $1.98 EPS versus a $1.73 consensus on $487.03 million in revenue, and shares traded up about 1.6% to $117.15.
• Insiders bought 37,236 shares (~$3.75M) last quarter—including a director purchase of 8,890 shares—while analyst coverage is mixed with a consensus Moderate Buy and an average target of $150.

Adtalem Global Education (NYSE:CVSA - Get Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided EPS guidance of 7.950-8.150 for the period, compared to the consensus EPS estimate of 7.900. The company issued revenue guidance of $1.9 billion-$1.9 billion, compared to the consensus revenue estimate of $1.9 billion.

Analyst Upgrades and Downgrades

CVSA has been the subject of several research analyst reports. Truist Financial assumed coverage on Adtalem Global Education in a report on Tuesday, March 24th. They issued a "buy" rating and a $130.00 price objective for the company. Barrington Research restated an "outperform" rating and set a $170.00 price target on shares of Adtalem Global Education in a research note on Friday, April 17th. Zacks Research cut Adtalem Global Education from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, March 25th. Finally, Weiss Ratings assumed coverage on Adtalem Global Education in a research note on Wednesday, February 25th. They set a "hold (c+)" rating for the company. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat.com, Adtalem Global Education presently has a consensus rating of "Moderate Buy" and an average target price of $150.00.

Adtalem Global Education Trading Up 1.6%

Shares of Adtalem Global Education stock traded up $1.84 during trading hours on Thursday, hitting $117.15. 382,964 shares of the company were exchanged, compared to its average volume of 390,387. Adtalem Global Education has a 1 year low of $86.97 and a 1 year high of $156.26. The company has a quick ratio of 0.68, a current ratio of 0.68 and a debt-to-equity ratio of 0.37. The firm has a 50-day simple moving average of $110.78. The firm has a market capitalization of $4.04 billion, a PE ratio of 17.20, a price-to-earnings-growth ratio of 1.00 and a beta of 0.63.

Adtalem Global Education (NYSE:CVSA - Get Free Report) last released its quarterly earnings data on Thursday, May 7th. The company reported $1.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.73 by $0.25. The firm had revenue of $487.03 million during the quarter. Adtalem Global Education had a return on equity of 20.24% and a net margin of 13.41%.Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. As a group, research analysts anticipate that Adtalem Global Education will post 7.86 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Michael W. Malafronte bought 8,890 shares of the stock in a transaction on Wednesday, March 11th. The shares were bought at an average price of $100.94 per share, with a total value of $897,356.60. Following the completion of the acquisition, the director owned 25,395 shares of the company's stock, valued at approximately $2,563,371.30. This trade represents a 53.86% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders acquired a total of 37,236 shares of company stock valued at $3,752,866 over the last quarter. 2.50% of the stock is currently owned by corporate insiders.

Adtalem Global Education Company Profile

Adtalem Global Education NYSE: CVSA is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.